Vaccine-Preventable Diseases

Hepatitis B vaccines are currently available to help protect patients against the infection caused by the hepatitis B virus.

RECOMBIVAX HB^® [hepatitis B vaccine (recombinant)] is indicated for immunization against infection caused by the hepatitis B virus.

Vaccination with RECOMBIVAX HB^® is recommended in persons of all ages, especially those who are at increased risk of infection with hepatitis B virus (for details, see above section “Who is at risk for hepatitis B?”). RECOMBIVAX HB^®* will not prevent hepatitis caused by other agents, such as hepatitis A virus, non-A, non-B hepatitis viruses, or other viruses known to infect the liver. Persons with a history of hypersensitivity (allergies) to any of the components of the vaccine should not be vaccinated with RECOMBIVAX HB^®.

*Hepatitis B vaccines are not indicated to prevent complications associated with hepatitis B.

This product information is intended only for residents of Canada.

RECOMBIVAX HB® [hepatitis B vaccine(recombinant)] is a Registered Trademark of Merck & Co., Inc. Used under license.